Skip to content
Screener

Innoviva, Inc. INVA Total Cost of Revenue

Total Cost of Revenue at other companies

Pfizer logo
PfizerPFE
$4.09B+8.3%
Merck & Co. logo
Merck & Co.MRK
$4.4B+23.6%
AbbVie logo
AbbVieABBV
$4.29B-1.3%
Insmed logo
InsmedINSM
$67.21M+139%
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
$2.21M+91.9%
Rigel Pharmaceuticals logo
Rigel PharmaceuticalsRIGL
$4.61M+4.5%

Other financials

Income statement

See full
Revenue$119.6M+19.3%
Gross profit$90.6M+9.0%
Operating income$50.9M+4.3%
Net income-$83.4M-231%
EPS (diluted)-$1.14-248%

Balance sheet

See full
Cash & equivalents$570.4M+43.5%
Total debt$269.7M-40.2%
Total equity$1.2B
Total assets$1.7B+27.7%

Cash flow

See full
Operating cash flow$52.0M+17.9%
CapEx$429.0K
Free cash flow$51.5M+16.9%

Valuation

See full
Market cap$1.53B+33.1%
Enterprise value$1.22B+2.1%
P/E4.3×-25.4×
P/S3.5×+0.4×

Profitability

See full
Gross margin72.2%-10.9pp
Operating margin36.9%-10.7pp
Net margin81.2%+70.8pp
FCF margin43.1%-11.1pp

Returns & leverage

See full
Return on equity29.1%
Debt / equity0.2×
Current ratio16×+13.4×

FAQ

What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.